Karyopharm Therapeutics, Inc. (KPTI)
1.855
-0.20
(-9.95%)
USD |
NASDAQ |
Sep 01, 16:00
1.855
0.00 (0.00%)
After-Hours: 16:32
Karyopharm Therapeutics Total Long Term Debt (Quarterly) : 255.12M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 255.12M |
| March 31, 2026 | 229.86M |
| December 31, 2025 | 232.64M |
| September 30, 2025 | 195.50M |
| June 30, 2025 | 189.24M |
| March 31, 2025 | 185.78M |
| December 31, 2024 | 194.09M |
| September 30, 2024 | 190.59M |
| June 30, 2024 | 192.09M |
| March 31, 2024 | 173.01M |
| December 31, 2023 | 173.71M |
| September 30, 2023 | 174.37M |
| June 30, 2023 | 175.00M |
| March 31, 2023 | 175.62M |
| December 31, 2022 | 176.20M |
| September 30, 2022 | 176.76M |
| June 30, 2022 | 310.28M |
| March 31, 2022 | 310.78M |
| December 31, 2021 | 178.26M |
| September 30, 2021 | 311.20M |
| June 30, 2021 | 311.58M |
| March 31, 2021 | 252.54M |
| December 31, 2020 | 129.21M |
| September 30, 2020 | 201.19M |
| June 30, 2020 | 199.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 124.52M |
| December 31, 2019 | 123.06M |
| September 30, 2019 | 121.60M |
| June 30, 2019 | 120.21M |
| March 31, 2019 | 118.82M |
| December 31, 2018 | 102.66M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 346.72M |
| Relay Therapeutics, Inc. | 26.64M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |